Global Hepatitis B Vaccines Supply, Demand and Key Producers, 2024-2030

Description

Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses given after that. This includes those with poor immune function such as from HIV/AIDS and those born premature. It is also recommended that health-care workers be vaccinated. In healthy people routine immunization results in more than 95% of people being protected.

The global Hepatitis B Vaccines market size is expected to reach $ 2025 million by 2030, rising at a market growth of 6.3% CAGR during the forecast period (2024-2030).

Global key players of Hepatitis B Vaccines include GSK, Dynavax, NCPC, etc. The top three players hold a share about 65%. North America is the largest market, and has a share about 45%, followed by Asia-Pacific and Europe with share 31% and 17%, separately. In terms of product type, Yeast Derived is the largest segment, occupied for a share of 85%. In terms of application, Adult is the largest field with a share about 64 percent.

This report studies the global Hepatitis B Vaccines production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Hepatitis B Vaccines and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hepatitis B Vaccines that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Hepatitis B Vaccines total production and demand, 2019-2030, (M Doses)
Global Hepatitis B Vaccines total production value, 2019-2030, (USD Million)
Global Hepatitis B Vaccines production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (M Doses), (based on production site)
Global Hepatitis B Vaccines consumption by region & country, CAGR, 2019-2030 & (M Doses)
U.S. VS China: Hepatitis B Vaccines domestic production, consumption, key domestic manufacturers and share
Global Hepatitis B Vaccines production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (M Doses)
Global Hepatitis B Vaccines production by Type, production, value, CAGR, 2019-2030, (USD Million) & (M Doses)
Global Hepatitis B Vaccines production by Application, production, value, CAGR, 2019-2030, (USD Million) & (M Doses)
This report profiles key players in the global Hepatitis B Vaccines market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, NCPC, Merck, Bio Kangtai, Dynavax, AIM Vaccine, KM Biologics, LG Life Sciences, Serum Institute, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hepatitis B Vaccines market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Doses) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Hepatitis B Vaccines Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Hepatitis B Vaccines Market, Segmentation by Type:
    Yeast Derived
    CHO Derived

Global Hepatitis B Vaccines Market, Segmentation by Application:
    Children
    Adult

Companies Profiled:
    GSK
    NCPC
    Merck
    Bio Kangtai
    Dynavax
    AIM Vaccine
    KM Biologics
    LG Life Sciences
    Serum Institute

Key Questions Answered:
1. How big is the global Hepatitis B Vaccines market?
2. What is the demand of the global Hepatitis B Vaccines market?
3. What is the year over year growth of the global Hepatitis B Vaccines market?
4. What is the production and production value of the global Hepatitis B Vaccines market?
5. Who are the key producers in the global Hepatitis B Vaccines market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Hepatitis B Vaccines Introduction
    1.2 World Hepatitis B Vaccines Supply & Forecast
        1.2.1 World Hepatitis B Vaccines Production Value (2019 & 2023 & 2030)
        1.2.2 World Hepatitis B Vaccines Production (2019-2030)
        1.2.3 World Hepatitis B Vaccines Pricing Trends (2019-2030)
    1.3 World Hepatitis B Vaccines Production by Region (Based on Production Site)
        1.3.1 World Hepatitis B Vaccines Production Value by Region (2019-2030)
        1.3.2 World Hepatitis B Vaccines Production by Region (2019-2030)
        1.3.3 World Hepatitis B Vaccines Average Price by Region (2019-2030)
        1.3.4 North America Hepatitis B Vaccines Production (2019-2030)
        1.3.5 Europe Hepatitis B Vaccines Production (2019-2030)
        1.3.6 China Hepatitis B Vaccines Production (2019-2030)
        1.3.7 Japan Hepatitis B Vaccines Production (2019-2030)
        1.3.8 South Korea Hepatitis B Vaccines Production (2019-2030)
        1.3.9 India Hepatitis B Vaccines Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Hepatitis B Vaccines Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Hepatitis B Vaccines Major Market Trends

2 Demand Summary
    2.1 World Hepatitis B Vaccines Demand (2019-2030)
    2.2 World Hepatitis B Vaccines Consumption by Region
        2.2.1 World Hepatitis B Vaccines Consumption by Region (2019-2024)
        2.2.2 World Hepatitis B Vaccines Consumption Forecast by Region (2025-2030)
    2.3 United States Hepatitis B Vaccines Consumption (2019-2030)
    2.4 China Hepatitis B Vaccines Consumption (2019-2030)
    2.5 Europe Hepatitis B Vaccines Consumption (2019-2030)
    2.6 Japan Hepatitis B Vaccines Consumption (2019-2030)
    2.7 South Korea Hepatitis B Vaccines Consumption (2019-2030)
    2.8 ASEAN Hepatitis B Vaccines Consumption (2019-2030)
    2.9 India Hepatitis B Vaccines Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Hepatitis B Vaccines Production Value by Manufacturer (2019-2024)
    3.2 World Hepatitis B Vaccines Production by Manufacturer (2019-2024)
    3.3 World Hepatitis B Vaccines Average Price by Manufacturer (2019-2024)
    3.4 Hepatitis B Vaccines Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Hepatitis B Vaccines Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Hepatitis B Vaccines in 2023
        3.5.3 Global Concentration Ratios (CR8) for Hepatitis B Vaccines in 2023
    3.6 Hepatitis B Vaccines Market: Overall Company Footprint Analysis
        3.6.1 Hepatitis B Vaccines Market: Region Footprint
        3.6.2 Hepatitis B Vaccines Market: Company Product Type Footprint
        3.6.3 Hepatitis B Vaccines Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Hepatitis B Vaccines Production Value Comparison
        4.1.1 United States VS China: Hepatitis B Vaccines Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Hepatitis B Vaccines Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Hepatitis B Vaccines Production Comparison
        4.2.1 United States VS China: Hepatitis B Vaccines Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Hepatitis B Vaccines Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Hepatitis B Vaccines Consumption Comparison
        4.3.1 United States VS China: Hepatitis B Vaccines Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Hepatitis B Vaccines Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Hepatitis B Vaccines Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Hepatitis B Vaccines Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Hepatitis B Vaccines Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Hepatitis B Vaccines Production (2019-2024)
    4.5 China Based Hepatitis B Vaccines Manufacturers and Market Share
        4.5.1 China Based Hepatitis B Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Hepatitis B Vaccines Production Value (2019-2024)
        4.5.3 China Based Manufacturers Hepatitis B Vaccines Production (2019-2024)
    4.6 Rest of World Based Hepatitis B Vaccines Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Hepatitis B Vaccines Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Hepatitis B Vaccines Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Hepatitis B Vaccines Production (2019-2024)

5 Market Analysis by Type
    5.1 World Hepatitis B Vaccines Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Yeast Derived
        5.2.2 CHO Derived
    5.3 Market Segment by Type
        5.3.1 World Hepatitis B Vaccines Production by Type (2019-2030)
        5.3.2 World Hepatitis B Vaccines Production Value by Type (2019-2030)
        5.3.3 World Hepatitis B Vaccines Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Hepatitis B Vaccines Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Children
        6.2.2 Adult
    6.3 Market Segment by Application
        6.3.1 World Hepatitis B Vaccines Production by Application (2019-2030)
        6.3.2 World Hepatitis B Vaccines Production Value by Application (2019-2030)
        6.3.3 World Hepatitis B Vaccines Average Price by Application (2019-2030)

7 Company Profiles
    7.1 GSK
        7.1.1 GSK Details
        7.1.2 GSK Major Business
        7.1.3 GSK Hepatitis B Vaccines Product and Services
        7.1.4 GSK Hepatitis B Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 GSK Recent Developments/Updates
        7.1.6 GSK Competitive Strengths & Weaknesses
    7.2 NCPC
        7.2.1 NCPC Details
        7.2.2 NCPC Major Business
        7.2.3 NCPC Hepatitis B Vaccines Product and Services
        7.2.4 NCPC Hepatitis B Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 NCPC Recent Developments/Updates
        7.2.6 NCPC Competitive Strengths & Weaknesses
    7.3 Merck
        7.3.1 Merck Details
        7.3.2 Merck Major Business
        7.3.3 Merck Hepatitis B Vaccines Product and Services
        7.3.4 Merck Hepatitis B Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Merck Recent Developments/Updates
        7.3.6 Merck Competitive Strengths & Weaknesses
    7.4 Bio Kangtai
        7.4.1 Bio Kangtai Details
        7.4.2 Bio Kangtai Major Business
        7.4.3 Bio Kangtai Hepatitis B Vaccines Product and Services
        7.4.4 Bio Kangtai Hepatitis B Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Bio Kangtai Recent Developments/Updates
        7.4.6 Bio Kangtai Competitive Strengths & Weaknesses
    7.5 Dynavax
        7.5.1 Dynavax Details
        7.5.2 Dynavax Major Business
        7.5.3 Dynavax Hepatitis B Vaccines Product and Services
        7.5.4 Dynavax Hepatitis B Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Dynavax Recent Developments/Updates
        7.5.6 Dynavax Competitive Strengths & Weaknesses
    7.6 AIM Vaccine
        7.6.1 AIM Vaccine Details
        7.6.2 AIM Vaccine Major Business
        7.6.3 AIM Vaccine Hepatitis B Vaccines Product and Services
        7.6.4 AIM Vaccine Hepatitis B Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 AIM Vaccine Recent Developments/Updates
        7.6.6 AIM Vaccine Competitive Strengths & Weaknesses
    7.7 KM Biologics
        7.7.1 KM Biologics Details
        7.7.2 KM Biologics Major Business
        7.7.3 KM Biologics Hepatitis B Vaccines Product and Services
        7.7.4 KM Biologics Hepatitis B Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 KM Biologics Recent Developments/Updates
        7.7.6 KM Biologics Competitive Strengths & Weaknesses
    7.8 LG Life Sciences
        7.8.1 LG Life Sciences Details
        7.8.2 LG Life Sciences Major Business
        7.8.3 LG Life Sciences Hepatitis B Vaccines Product and Services
        7.8.4 LG Life Sciences Hepatitis B Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 LG Life Sciences Recent Developments/Updates
        7.8.6 LG Life Sciences Competitive Strengths & Weaknesses
    7.9 Serum Institute
        7.9.1 Serum Institute Details
        7.9.2 Serum Institute Major Business
        7.9.3 Serum Institute Hepatitis B Vaccines Product and Services
        7.9.4 Serum Institute Hepatitis B Vaccines Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Serum Institute Recent Developments/Updates
        7.9.6 Serum Institute Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Hepatitis B Vaccines Industry Chain
    8.2 Hepatitis B Vaccines Upstream Analysis
        8.2.1 Hepatitis B Vaccines Core Raw Materials
        8.2.2 Main Manufacturers of Hepatitis B Vaccines Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Hepatitis B Vaccines Production Mode
    8.6 Hepatitis B Vaccines Procurement Model
    8.7 Hepatitis B Vaccines Industry Sales Model and Sales Channels
        8.7.1 Hepatitis B Vaccines Sales Model
        8.7.2 Hepatitis B Vaccines Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Hepatitis B Vaccines Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Hepatitis B Vaccines Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Hepatitis B Vaccines Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Hepatitis B Vaccines Production Value Market Share by Region (2019-2024)
 Table 5. World Hepatitis B Vaccines Production Value Market Share by Region (2025-2030)
 Table 6. World Hepatitis B Vaccines Production by Region (2019-2024) & (M Doses)
 Table 7. World Hepatitis B Vaccines Production by Region (2025-2030) & (M Doses)
 Table 8. World Hepatitis B Vaccines Production Market Share by Region (2019-2024)
 Table 9. World Hepatitis B Vaccines Production Market Share by Region (2025-2030)
 Table 10. World Hepatitis B Vaccines Average Price by Region (2019-2024) & (US$/Dose)
 Table 11. World Hepatitis B Vaccines Average Price by Region (2025-2030) & (US$/Dose)
 Table 12. Hepatitis B Vaccines Major Market Trends
 Table 13. World Hepatitis B Vaccines Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (M Doses)
 Table 14. World Hepatitis B Vaccines Consumption by Region (2019-2024) & (M Doses)
 Table 15. World Hepatitis B Vaccines Consumption Forecast by Region (2025-2030) & (M Doses)
 Table 16. World Hepatitis B Vaccines Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Hepatitis B Vaccines Producers in 2023
 Table 18. World Hepatitis B Vaccines Production by Manufacturer (2019-2024) & (M Doses)
 Table 19. Production Market Share of Key Hepatitis B Vaccines Producers in 2023
 Table 20. World Hepatitis B Vaccines Average Price by Manufacturer (2019-2024) & (US$/Dose)
 Table 21. Global Hepatitis B Vaccines Company Evaluation Quadrant
 Table 22. World Hepatitis B Vaccines Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Hepatitis B Vaccines Production Site of Key Manufacturer
 Table 24. Hepatitis B Vaccines Market: Company Product Type Footprint
 Table 25. Hepatitis B Vaccines Market: Company Product Application Footprint
 Table 26. Hepatitis B Vaccines Competitive Factors
 Table 27. Hepatitis B Vaccines New Entrant and Capacity Expansion Plans
 Table 28. Hepatitis B Vaccines Mergers & Acquisitions Activity
 Table 29. United States VS China Hepatitis B Vaccines Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Hepatitis B Vaccines Production Comparison, (2019 & 2023 & 2030) & (M Doses)
 Table 31. United States VS China Hepatitis B Vaccines Consumption Comparison, (2019 & 2023 & 2030) & (M Doses)
 Table 32. United States Based Hepatitis B Vaccines Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Hepatitis B Vaccines Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Hepatitis B Vaccines Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Hepatitis B Vaccines Production (2019-2024) & (M Doses)
 Table 36. United States Based Manufacturers Hepatitis B Vaccines Production Market Share (2019-2024)
 Table 37. China Based Hepatitis B Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Hepatitis B Vaccines Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Hepatitis B Vaccines Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Hepatitis B Vaccines Production, (2019-2024) & (M Doses)
 Table 41. China Based Manufacturers Hepatitis B Vaccines Production Market Share (2019-2024)
 Table 42. Rest of World Based Hepatitis B Vaccines Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Hepatitis B Vaccines Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Hepatitis B Vaccines Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Hepatitis B Vaccines Production, (2019-2024) & (M Doses)
 Table 46. Rest of World Based Manufacturers Hepatitis B Vaccines Production Market Share (2019-2024)
 Table 47. World Hepatitis B Vaccines Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Hepatitis B Vaccines Production by Type (2019-2024) & (M Doses)
 Table 49. World Hepatitis B Vaccines Production by Type (2025-2030) & (M Doses)
 Table 50. World Hepatitis B Vaccines Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Hepatitis B Vaccines Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Hepatitis B Vaccines Average Price by Type (2019-2024) & (US$/Dose)
 Table 53. World Hepatitis B Vaccines Average Price by Type (2025-2030) & (US$/Dose)
 Table 54. World Hepatitis B Vaccines Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Hepatitis B Vaccines Production by Application (2019-2024) & (M Doses)
 Table 56. World Hepatitis B Vaccines Production by Application (2025-2030) & (M Doses)
 Table 57. World Hepatitis B Vaccines Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Hepatitis B Vaccines Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Hepatitis B Vaccines Average Price by Application (2019-2024) & (US$/Dose)
 Table 60. World Hepatitis B Vaccines Average Price by Application (2025-2030) & (US$/Dose)
 Table 61. GSK Basic Information, Manufacturing Base and Competitors
 Table 62. GSK Major Business
 Table 63. GSK Hepatitis B Vaccines Product and Services
 Table 64. GSK Hepatitis B Vaccines Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. GSK Recent Developments/Updates
 Table 66. GSK Competitive Strengths & Weaknesses
 Table 67. NCPC Basic Information, Manufacturing Base and Competitors
 Table 68. NCPC Major Business
 Table 69. NCPC Hepatitis B Vaccines Product and Services
 Table 70. NCPC Hepatitis B Vaccines Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. NCPC Recent Developments/Updates
 Table 72. NCPC Competitive Strengths & Weaknesses
 Table 73. Merck Basic Information, Manufacturing Base and Competitors
 Table 74. Merck Major Business
 Table 75. Merck Hepatitis B Vaccines Product and Services
 Table 76. Merck Hepatitis B Vaccines Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Merck Recent Developments/Updates
 Table 78. Merck Competitive Strengths & Weaknesses
 Table 79. Bio Kangtai Basic Information, Manufacturing Base and Competitors
 Table 80. Bio Kangtai Major Business
 Table 81. Bio Kangtai Hepatitis B Vaccines Product and Services
 Table 82. Bio Kangtai Hepatitis B Vaccines Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. Bio Kangtai Recent Developments/Updates
 Table 84. Bio Kangtai Competitive Strengths & Weaknesses
 Table 85. Dynavax Basic Information, Manufacturing Base and Competitors
 Table 86. Dynavax Major Business
 Table 87. Dynavax Hepatitis B Vaccines Product and Services
 Table 88. Dynavax Hepatitis B Vaccines Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. Dynavax Recent Developments/Updates
 Table 90. Dynavax Competitive Strengths & Weaknesses
 Table 91. AIM Vaccine Basic Information, Manufacturing Base and Competitors
 Table 92. AIM Vaccine Major Business
 Table 93. AIM Vaccine Hepatitis B Vaccines Product and Services
 Table 94. AIM Vaccine Hepatitis B Vaccines Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. AIM Vaccine Recent Developments/Updates
 Table 96. AIM Vaccine Competitive Strengths & Weaknesses
 Table 97. KM Biologics Basic Information, Manufacturing Base and Competitors
 Table 98. KM Biologics Major Business
 Table 99. KM Biologics Hepatitis B Vaccines Product and Services
 Table 100. KM Biologics Hepatitis B Vaccines Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 101. KM Biologics Recent Developments/Updates
 Table 102. KM Biologics Competitive Strengths & Weaknesses
 Table 103. LG Life Sciences Basic Information, Manufacturing Base and Competitors
 Table 104. LG Life Sciences Major Business
 Table 105. LG Life Sciences Hepatitis B Vaccines Product and Services
 Table 106. LG Life Sciences Hepatitis B Vaccines Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 107. LG Life Sciences Recent Developments/Updates
 Table 108. LG Life Sciences Competitive Strengths & Weaknesses
 Table 109. Serum Institute Basic Information, Manufacturing Base and Competitors
 Table 110. Serum Institute Major Business
 Table 111. Serum Institute Hepatitis B Vaccines Product and Services
 Table 112. Serum Institute Hepatitis B Vaccines Production (M Doses), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 113. Serum Institute Recent Developments/Updates
 Table 114. Serum Institute Competitive Strengths & Weaknesses
 Table 115. Global Key Players of Hepatitis B Vaccines Upstream (Raw Materials)
 Table 116. Global Hepatitis B Vaccines Typical Customers
 Table 117. Hepatitis B Vaccines Typical Distributors


List of Figures
 Figure 1. Hepatitis B Vaccines Picture
 Figure 2. World Hepatitis B Vaccines Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Hepatitis B Vaccines Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Hepatitis B Vaccines Production (2019-2030) & (M Doses)
 Figure 5. World Hepatitis B Vaccines Average Price (2019-2030) & (US$/Dose)
 Figure 6. World Hepatitis B Vaccines Production Value Market Share by Region (2019-2030)
 Figure 7. World Hepatitis B Vaccines Production Market Share by Region (2019-2030)
 Figure 8. North America Hepatitis B Vaccines Production (2019-2030) & (M Doses)
 Figure 9. Europe Hepatitis B Vaccines Production (2019-2030) & (M Doses)
 Figure 10. China Hepatitis B Vaccines Production (2019-2030) & (M Doses)
 Figure 11. Japan Hepatitis B Vaccines Production (2019-2030) & (M Doses)
 Figure 12. South Korea Hepatitis B Vaccines Production (2019-2030) & (M Doses)
 Figure 13. India Hepatitis B Vaccines Production (2019-2030) & (M Doses)
 Figure 14. Hepatitis B Vaccines Market Drivers
 Figure 15. Factors Affecting Demand
 Figure 16. World Hepatitis B Vaccines Consumption (2019-2030) & (M Doses)
 Figure 17. World Hepatitis B Vaccines Consumption Market Share by Region (2019-2030)
 Figure 18. United States Hepatitis B Vaccines Consumption (2019-2030) & (M Doses)
 Figure 19. China Hepatitis B Vaccines Consumption (2019-2030) & (M Doses)
 Figure 20. Europe Hepatitis B Vaccines Consumption (2019-2030) & (M Doses)
 Figure 21. Japan Hepatitis B Vaccines Consumption (2019-2030) & (M Doses)
 Figure 22. South Korea Hepatitis B Vaccines Consumption (2019-2030) & (M Doses)
 Figure 23. ASEAN Hepatitis B Vaccines Consumption (2019-2030) & (M Doses)
 Figure 24. India Hepatitis B Vaccines Consumption (2019-2030) & (M Doses)
 Figure 25. Producer Shipments of Hepatitis B Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 26. Global Four-firm Concentration Ratios (CR4) for Hepatitis B Vaccines Markets in 2023
 Figure 27. Global Four-firm Concentration Ratios (CR8) for Hepatitis B Vaccines Markets in 2023
 Figure 28. United States VS China: Hepatitis B Vaccines Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States VS China: Hepatitis B Vaccines Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 30. United States VS China: Hepatitis B Vaccines Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 31. United States Based Manufacturers Hepatitis B Vaccines Production Market Share 2023
 Figure 32. China Based Manufacturers Hepatitis B Vaccines Production Market Share 2023
 Figure 33. Rest of World Based Manufacturers Hepatitis B Vaccines Production Market Share 2023
 Figure 34. World Hepatitis B Vaccines Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 35. World Hepatitis B Vaccines Production Value Market Share by Type in 2023
 Figure 36. Yeast Derived
 Figure 37. CHO Derived
 Figure 38. World Hepatitis B Vaccines Production Market Share by Type (2019-2030)
 Figure 39. World Hepatitis B Vaccines Production Value Market Share by Type (2019-2030)
 Figure 40. World Hepatitis B Vaccines Average Price by Type (2019-2030) & (US$/Dose)
 Figure 41. World Hepatitis B Vaccines Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 42. World Hepatitis B Vaccines Production Value Market Share by Application in 2023
 Figure 43. Children
 Figure 44. Adult
 Figure 45. World Hepatitis B Vaccines Production Market Share by Application (2019-2030)
 Figure 46. World Hepatitis B Vaccines Production Value Market Share by Application (2019-2030)
 Figure 47. World Hepatitis B Vaccines Average Price by Application (2019-2030) & (US$/Dose)
 Figure 48. Hepatitis B Vaccines Industry Chain
 Figure 49. Hepatitis B Vaccines Procurement Model
 Figure 50. Hepatitis B Vaccines Sales Model
 Figure 51. Hepatitis B Vaccines Sales Channels, Direct Sales, and Distribution
 Figure 52. Methodology
 Figure 53. Research Process and Data Source

Companies Mentioned

GSK
NCPC
Merck
Bio Kangtai
Dynavax
AIM Vaccine
KM Biologics
LG Life Sciences
Serum Institute